Astellas Pharma Inc. (ALPMY.PK, ALPMF.PK) late Sunday said that Songlin Xue has been named head of Global Pharmacovigilance or GPV. He will be located at Astellas' Headquarters for the Americas in Northbrook, Illinois, USA.
Xue will report to Sef Kurstjens, newly named Chief Medical Officer at Astellas. Astellas established the Chief Medical Officer position in April to further integrate and enhance its delivery of global medical solutions.
During his over twenty years in the pharmaceutical industry, Xue has held increasingly senior roles with global responsibilities in drug safety and pharmacoepidemiology.
Most recently, Xue held the position of Senior Vice President, Head Global Pharmacovigilance at Takeda Pharmaceuticals, Inc. Prior to joining Takeda, Xue held posts with global pharmaceutical companies such as Novartis and Wyeth.
With Xue's appointment, Astellas has now completed the hiring of global heads in the areas of PV, Medical Affairs, Regulatory Affairs, Clinical and Research Quality Assurance and Quality Assurance.
For comments and feedback: editorial@rttnews.com